TREATMENT OF OSTEOPOROSIS WITH INTRANASAL CALCITONIN

鼻内降钙素治疗骨质疏松症

• 批准号: 6113841
• 负责人: DAVID J ONTJES
• 金额: $ 1.58万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6113841
• 关键词: calcitonin; calcium; clinical research; excretion; female; hormone therapy; human subject; human therapy evaluation; inhalation drug administration; osteoporosis; skeletal disorder chemotherapy; urinalysis

Osteoporotic women excrete more calcium in their urine than do normal women after ingestion of a standardized meal. Subcutaneous injection of calcitonin prevented the increase in excretion of calcium. The present study will assess whether intranasal administration of calcitonin will also reduce urinary calcium excretion in osteoporotic women.

骨质疏松女性在尿液中排出的钙比正常女性多 摄入标准化膳食后的女性。 皮下注射 降钙素可阻止钙排泄的增加。 这 本研究将评估鼻内给药是否 降钙素还会减少骨质疏松症患者尿钙的排泄 女性。